{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T02:21:04Z","timestamp":1787710864537,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"An intramural grant from our hospital","award":["YGQ-202504"],"award-info":[{"award-number":["YGQ-202504"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02226-x","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:07:02Z","timestamp":1781680022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic role of preoperative plasma fibrinogen-to-albumin ratio in urological carcinomas: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhengqing","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"10","key":"2226_CR1","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1161\/ATVBAHA.124.321603","volume":"45","author":"Y Hisada","year":"2025","unstructured":"Hisada Y, Mackman N. Profibrinolytic Factors and Cancer Progression, Metastasis, and Survival. Arterioscler Thromb Vasc Biol. 2025;45(10):1732\u201341. https:\/\/doi.org\/10.1161\/ATVBAHA.124.321603.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2226_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1055\/s-0039-1693472","volume":"45","author":"BK Sharma","year":"2019","unstructured":"Sharma BK, Flick MJ, Palumbo JS. Cancer-Associated Thrombosis: A Two-Way Street. Semin Thromb Hemost. 2019;45(6):559\u201368. https:\/\/doi.org\/10.1055\/s-0039-1693472.","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"2226_CR3","doi-asserted-by":"publisher","first-page":"98725","DOI":"10.4251\/wjgo.v17.i1.98725","volume":"17","author":"YQ Shen","year":"2025","unstructured":"Shen YQ, Wei QW, Tian YR, Ling YZ, Zhang M. Coagulation indices and fibrinogen degradation products as predictive biomarkers for tumor-node-metastasis staging and metastasis in gastric cancer. World J Gastrointest Oncol. 2025;17(1):98725. https:\/\/doi.org\/10.4251\/wjgo.v17.i1.98725.","journal-title":"World J Gastrointest Oncol"},{"issue":"11","key":"2226_CR4","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493\u201303. https:\/\/doi.org\/10.1016\/S1470-2045(14)70263-3.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2226_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-025-02243-8","volume":"24","author":"Y Xie","year":"2025","unstructured":"Xie Y, Liu F, Wu Y, Zhu Y, Jiang Y, Wu Q, Dong Z, Liu K. Inflammation in cancer: therapeutic opportunities from new insights. Mol Cancer. 2025;24(1):51. https:\/\/doi.org\/10.1186\/s12943-025-02243-8.","journal-title":"Mol Cancer"},{"issue":"2","key":"2226_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/aja.aja_38_19","volume":"22","author":"H Xu","year":"2020","unstructured":"Xu H, Ai JZ, Tan P, Lin TH, Jin X, Gong LN, Lei HR, Yang L, Wei Q. Pretreatment elevated fibrinogen level predicts worse oncologic outcomes in upper tract urothelial carcinoma. Asian J Androl. 2020;22(2):177\u201383. https:\/\/doi.org\/10.4103\/aja.aja_38_19.","journal-title":"Asian J Androl"},{"key":"2226_CR7","doi-asserted-by":"publisher","first-page":"1360595","DOI":"10.3389\/fendo.2024.1360595","volume":"15","author":"Z Bao","year":"2024","unstructured":"Bao Z, Li G, He F, Xu X, Liu Z, Wang J. The prognostic value of preoperative plasma fibrinogen in Asian patients with urothelial cancer: a systematic review and meta-analysis. Front Endocrinol. 2024;15:1360595. https:\/\/doi.org\/10.3389\/fendo.2024.1360595.","journal-title":"Front Endocrinol"},{"issue":"9","key":"2226_CR8","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.21873\/anticanres.16615","volume":"43","author":"S Sekito","year":"2023","unstructured":"Sekito S, Tanaka S, Kitano G, Kato M, Ogura Y, Kojima T. Pre-operative Plasma Fibrinogen Level as a Potential Predictor of Pathological T3 Upstaging in Clinically Localized Renal Cell Carcinoma. Anticancer Res. 2023;43(9):4229\u201335. https:\/\/doi.org\/10.21873\/anticanres.16615.","journal-title":"Anticancer Res"},{"key":"2226_CR9","doi-asserted-by":"publisher","unstructured":"Singla S, Goel A, Mishra S, Lohani R, Sankhwar SN, Singh SR. Role of plasma fibrinogen and D-dimer as prognostic biomarkers in patients with non-muscle invasive bladder cancer. Afr J Urol. 2023;29(1). https:\/\/doi.org\/10.1186\/s12301-023-00350-w.","DOI":"10.1186\/s12301-023-00350-w"},{"issue":"27","key":"2226_CR10","doi-asserted-by":"publisher","first-page":"e26548","DOI":"10.1097\/MD.0000000000026548","volume":"100","author":"C Shen","year":"2021","unstructured":"Shen C, Zhou K, Wang W, Zhang Y, Liu X. The prognostic value of preoperative serum albumin in patients with bladder urothelial carcinoma undergoing transurethral resection of bladder tumor: A prospective cohort study. Medicine. 2021;100(27):e26548. https:\/\/doi.org\/10.1097\/MD.0000000000026548.","journal-title":"Medicine"},{"issue":"11","key":"2226_CR11","doi-asserted-by":"publisher","first-page":"e1472","DOI":"10.1002\/cti2.1472","volume":"12","author":"J Saal","year":"2023","unstructured":"Saal J, Ellinger J, Ritter M, Brossart P, H\u00f6lzel M, Kl\u00fcmper N, Bald T. Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors. Clin Transl Immunol. 2023;12(11):e1472. https:\/\/doi.org\/10.1002\/cti2.1472.","journal-title":"Clin Transl Immunol"},{"key":"2226_CR12","doi-asserted-by":"publisher","first-page":"1566848","DOI":"10.3389\/fonc.2025.1566848","volume":"15","author":"H Xie","year":"2025","unstructured":"Xie H, Huang Y, Ban C, Wei W, Tang H, Huang Q, Su Z, Cheng Z, Liao T, Liao K, et al. LAR, FAR, and PLR as prognostic factors in high-grade urothelial carcinoma of the bladder after surgery. Front Oncol. 2025;15:1566848. https:\/\/doi.org\/10.3389\/fonc.2025.1566848.","journal-title":"Front Oncol"},{"key":"2226_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.04.026","author":"F Claps","year":"2021","unstructured":"Claps F, Rai S, Mir M, Rhijn B, Mazzon G, Davis L, Valadon C, Silvestri T, Rizzo M, Liguori G, et al. Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy. Urol Oncol. 2021. https:\/\/doi.org\/10.1016\/j.urolonc.2021.04.026.","journal-title":"Urol Oncol"},{"key":"2226_CR14","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.2147\/CMAR.S300574","volume":"13","author":"J Chen","year":"2021","unstructured":"Chen J, Hao L, Zhang S, Zhang Y, Dong B, Zhang Q, Han C. Preoperative fibrinogen\u2013albumin ratio, potential prognostic factors for bladder cancer patients undergoing radical cystectomy: A two-center study. Cancer Manag Res. 2021;13:3181\u201392. https:\/\/doi.org\/10.2147\/CMAR.S300574.","journal-title":"Cancer Manag Res"},{"key":"2226_CR15","doi-asserted-by":"publisher","first-page":"2895150","DOI":"10.1155\/2020\/2895150","volume":"2020","author":"C Ma","year":"2020","unstructured":"Ma C, Liu Q, Li C, Cheng J, Liu D, Yang Z, Yan H, Wu B, Wu Y, Zhao J. Novel blood indicators of progression and prognosis in renal cell carcinoma: Red cell distribution width-to-lymphocyte ratio and albumin-to-fibrinogen ratio. J Oncol. 2020;2020:2895150. https:\/\/doi.org\/10.1155\/2020\/2895150.","journal-title":"J Oncol"},{"issue":"3","key":"2226_CR16","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.21037\/tau-19-873","volume":"9","author":"J Liu","year":"2020","unstructured":"Liu J, Gan Y, Song H, Zhu K, Zhang Q. The predictive value of the preoperative fibrinogen-albumin ratio on the postoperative prognosis of renal cell carcinoma. Transl Androl Urol. 2020;9(3):1053\u201361. https:\/\/doi.org\/10.21037\/tau-19-873.","journal-title":"Transl Androl Urol"},{"key":"2226_CR17","doi-asserted-by":"publisher","first-page":"985377","DOI":"10.3389\/fonc.2022.985377","volume":"12","author":"B Li","year":"2022","unstructured":"Li B, Deng H, Lei B, Chen L, Zhang X, Sha D. The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: A meta-analysis. Front Oncol. 2022;12:985377. https:\/\/doi.org\/10.3389\/fonc.2022.985377.","journal-title":"Front Oncol"},{"issue":"19","key":"2226_CR18","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.7150\/jca.61068","volume":"12","author":"S Li","year":"2021","unstructured":"Li S, Zhang D, Zeng S, Wu T, Wang Y, Zhang H, Wang B, Hu X. Prognostic Value of Preoperative Albumin-to-Fibrinogen Ratio in Patients with Bladder Cancer. J Cancer. 2021;12(19):5864\u201373. https:\/\/doi.org\/10.7150\/jca.61068.","journal-title":"J Cancer"},{"issue":"1","key":"2226_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12894-022-01118-0","volume":"22","author":"O Demir","year":"2022","unstructured":"Demir O, Demirag G, Aslan G. Prospective evaluation of hematological parameters in preoperative renal cell cancer patients. BMC Urol. 2022;22(1):201. https:\/\/doi.org\/10.1186\/s12894-022-01118-0.","journal-title":"BMC Urol"},{"issue":"19","key":"2226_CR20","doi-asserted-by":"publisher","first-page":"11501","DOI":"10.3390\/ijms231911501","volume":"23","author":"S Salciccia","year":"2022","unstructured":"Salciccia S, Frisenda M, Bevilacqua G, Viscuso P, Casale P, Berardinis ED, Pierro GBD, Cattarino S, Giorgino G, Rosati D, et al. Prognostic Value of Albumin to Globulin Ratio in Non-Metastatic and Metastatic Prostate Cancer Patients: A Meta-Analysis and Systematic Review. Int J Mol Sci. 2022;23(19):11501. https:\/\/doi.org\/10.3390\/ijms231911501.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"2226_CR21","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.7150\/jca.21061","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Chen W, Hu C, Wen X, Pan J, Xu F, Zhu Y, Shao X, Shangguan X, Fan L, et al. Albumin and Fibrinogen Combined Prognostic Grade Predicts Prognosis of Patients with Prostate Cancer. J Cancer. 2017;8(19):3992\u201301. https:\/\/doi.org\/10.7150\/jca.21061.","journal-title":"J Cancer"},{"issue":"40","key":"2226_CR22","doi-asserted-by":"publisher","first-page":"68964","DOI":"10.18632\/oncotarget.16483","volume":"8","author":"J Cui","year":"2017","unstructured":"Cui J, Yu M, Zhang N, Wang S, Zhu Y, Chen S, Zhu K, Du J, Zhao H, Liu X, et al. Prognostic scores based on the preoperative plasma fibrinogen and serum albumin level as a prognostic factor in patients with upper urinary tract urothelial carcinoma. Oncotarget. 2017;8(40):68964\u201373. https:\/\/doi.org\/10.18632\/oncotarget.16483.","journal-title":"Oncotarget"},{"issue":"10","key":"2226_CR23","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.4240\/wjgs.v15.i10.2247","volume":"15","author":"XJ Zhang","year":"2023","unstructured":"Zhang XJ, Fei H, Sun CY, Li ZF, Li Z, Guo CG, Zhao DB. Novel prognostic score based on the preoperative total bilirubin-albumin ratio and fibrinogen-albumin ratio in ampullary adenocarcinoma. World J Gastrointest Surg. 2023;15(10):2247\u201358. https:\/\/doi.org\/10.4240\/wjgs.v15.i10.2247.","journal-title":"World J Gastrointest Surg"},{"issue":"36","key":"2226_CR24","doi-asserted-by":"publisher","first-page":"e34926","DOI":"10.1097\/MD.0000000000034926","volume":"102","author":"Y Fu","year":"2023","unstructured":"Fu Y, Yu Y, Zhou Y, Li T, Xie Y, Wang Y, Ran Q, Chen Y, Fan X. The fibrinogen-albumin ratio as a novel prognostic factor for elderly patients with osteosarcoma. Medicine. 2023;102(36):e34926. https:\/\/doi.org\/10.1097\/MD.0000000000034926.","journal-title":"Medicine"},{"key":"2226_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2147\/CMAR.S275173","volume":"13","author":"S Deng","year":"2021","unstructured":"Deng S, Fan Z, Xia H, Gong Y, Qian Y, Huang Q, Cheng H, Jin K, Xiao Z, Luo G, et al. Fibrinogen\/Albumin Ratio as a Promising Marker for Predicting Survival in Pancreatic Neuroendocrine Neoplasms. Cancer Manag Res. 2021;13:107\u201315. https:\/\/doi.org\/10.2147\/CMAR.S275173.","journal-title":"Cancer Manag Res"},{"issue":"14","key":"2226_CR26","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1002\/cam4.4035","volume":"10","author":"H Yu","year":"2021","unstructured":"Yu H, Wang M, Wang Y, Yang J, Deng L, Bao W, He B, Lin Z, Chen Z, Chen K, et al. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study. Cancer Med. 2021;10(14):4768\u201380. https:\/\/doi.org\/10.1002\/cam4.4035.","journal-title":"Cancer Med"},{"key":"2226_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cca.2018.04.012","volume":"482","author":"S Chen","year":"2018","unstructured":"Chen S, Yan H, Du J, Li J, Shen B, Ying H, Zhang Y, Chen S. Prognostic significance of pre-resection albumin\/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis. Clin Chim Acta. 2018;482:203\u201308. https:\/\/doi.org\/10.1016\/j.cca.2018.04.012.","journal-title":"Clin Chim Acta"},{"issue":"7","key":"2226_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1517\/14712598.3.7.1105","volume":"3","author":"CA Staton","year":"2003","unstructured":"Staton CA, Brown NJ, Lewis CE. The role of fibrinogen and related fragments in tumour angiogenesis and metastasis. Expert Opin Biol Ther. 2003;3(7):1105\u201320. https:\/\/doi.org\/10.1517\/14712598.3.7.1105.","journal-title":"Expert Opin Biol Ther"},{"key":"2226_CR29","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/1471-2407-14-566","volume":"14","author":"YJ Shu","year":"2014","unstructured":"Shu YJ, Weng H, Bao RF, Wu XS, Ding Q, Cao Y, Wang XA, Zhang F, Xiang SS, Li HF, et al. Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study. BMC Cancer. 2014;14:566. https:\/\/doi.org\/10.1186\/1471-2407-14-566.","journal-title":"BMC Cancer"},{"issue":"13","key":"2226_CR30","doi-asserted-by":"publisher","first-page":"7554","DOI":"10.1074\/jbc.273.13.7554","volume":"273","author":"A Sahni","year":"1998","unstructured":"Sahni A, Odrljin T, Francis CW. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem. 1998;273(13):7554\u201359. https:\/\/doi.org\/10.1074\/jbc.273.13.7554.","journal-title":"J Biol Chem"},{"issue":"12","key":"2226_CR31","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1182\/blood.V96.12.3772","volume":"96","author":"A Sahni","year":"2000","unstructured":"Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood. 2000;96(12):3772\u201378. PMID:11090059.","journal-title":"Blood"},{"key":"2226_CR32","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.2147\/CMAR.S292605","volume":"13","author":"C Chen","year":"2021","unstructured":"Chen C, Liu Y, Han P, Cui B. Research Progress of Preoperative FPR, FAR or AFR in Patients with Colorectal Cancer. Cancer Manag Res. 2021;13:1791\u201301. https:\/\/doi.org\/10.2147\/CMAR.S292605.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"2226_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3177\/jnsv.61.263","volume":"61","author":"Y Oe","year":"2015","unstructured":"Oe Y, Mochizuki K, Miyauchi R, Misaki Y, Kasezawa N, Tohyama K, Goda T. Plasma TNF-\u03b1 Is Associated with Inflammation and Nutrition Status in Community-Dwelling Japanese Elderly. J Nutr Sci Vitaminol (Tokyo). 2015;61(3):263\u201369. https:\/\/doi.org\/10.3177\/jnsv.61.263.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"Pt 10","key":"2226_CR34","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1242\/jcs.109.10.2571","volume":"109","author":"H Zoellner","year":"1996","unstructured":"Zoellner H, H\u00f6fler M, Beckmann R, Hufnagl P, Vanyek E, Bielek E, Wojta J, Fabry A, Lockie S, Binder BR. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci. 1996;109(Pt 10):2571\u201380. https:\/\/doi.org\/10.1242\/jcs.109.10.2571.","journal-title":"J Cell Sci"},{"issue":"4","key":"2226_CR35","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/s0008-6363(02)00492-3","volume":"55","author":"WJ Zhang","year":"2002","unstructured":"Zhang WJ, Frei B. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res. 2002;55(4):820\u20139. https:\/\/doi.org\/10.1016\/s0008-6363(02)00492-3.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"2226_CR36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","volume":"173","author":"SH Lee","year":"2018","unstructured":"Lee SH, Hu W, Matulay JT, Silva MV, Owczarek TB, Kim K, Chua CW, Barlow LJ, Kandoth C, Williams AB, et al. Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer. Cell. 2018;173(2):515\u2013e2817. https:\/\/doi.org\/10.1016\/j.cell.2018.03.017.","journal-title":"Cell"},{"issue":"13","key":"2226_CR37","doi-asserted-by":"publisher","first-page":"e2414558","DOI":"10.1002\/advs.202414558","volume":"12","author":"H Zhao","year":"2025","unstructured":"Zhao H, Lin N, Ho VWS, Liu K, Chen X, Wu H, Chiu PK-F, Huang L, Dantes Z, Wong KL, et al. Patient-Derived Bladder Cancer Organoids as a Valuable Tool for Understanding Tumor Biology and Developing Personalized Treatment. Adv Sci (Weinh). 2025;12(13):e2414558. https:\/\/doi.org\/10.1002\/advs.202414558.","journal-title":"Adv Sci (Weinh)"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02226-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02226-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02226-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T01:56:24Z","timestamp":1787709384000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02226-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2226"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02226-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9369671\/v1","asserted-by":"object"}]},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All included studies were published peer-reviewed articles with ethical approval obtained by the original authors, and no new animal or human studies were performed in this work. For the above reasons, there was no need to obtain additional ethical approval for this meta-analysis.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"209"}}